Sera Prognostics, Inc. (SERA) stock
SERANasdaqServices-Medical LaboratoriesFiscal year ends December 31
$2.00+0.06 (+3.09%)
Close on Nov 17, 2026Market cap $78.90MP/E –Yield –
Sera Prognostics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Sera Prognostics's revenue for the twelve months ending Jun 30, 2026 was $70.00K, down 35.2% year over year. For fiscal 2025 it was $81.00K, up 5.2% from the year before. The highest annual figure on record is $306.00K in fiscal 2023.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $81.00K | +5.2% |
| FY2024 | Dec 31, 2024 | $77.00K | -74.8% |
| FY2023 | Dec 31, 2023 | $306.00K | +14.2% |
| FY2022 | Dec 31, 2022 | $268.00K | +226.8% |
| FY2021 | Dec 31, 2021 | $82.00K | +228.0% |
| FY2020 | Dec 31, 2020 | $25.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $30.00K | +76.5% |
| Q1 FY2026 | Mar 31, 2026 | $14.00K | -63.2% |
| Q4 FY2025 | Dec 31, 2025 | $10.00K | -58.3% |
| Q3 FY2025 | Sep 30, 2025 | $16.00K | -44.8% |
| Q2 FY2025 | Jun 30, 2025 | $17.00K | -29.2% |
| Q1 FY2025 | Mar 31, 2025 | $38.00K | – |
| Q4 FY2024 | Dec 31, 2024 | $24.00K | -41.5% |
| Q3 FY2024 | Sep 30, 2024 | $29.00K | -31.0% |
| Q2 FY2024 | Jun 30, 2024 | $24.00K | -80.5% |
| Q1 FY2024 | Mar 31, 2024 | $0 | -100.0% |
| Q4 FY2023 | Dec 31, 2023 | $41.00K | -36.9% |
| Q3 FY2023 | Sep 30, 2023 | $42.00K | -51.7% |
| Q2 FY2023 | Jun 30, 2023 | $123.00K | +57.7% |
| Q1 FY2023 | Mar 31, 2023 | $100.00K | +163.2% |
| Q4 FY2022 | Dec 31, 2022 | $65.00K | +150.0% |
| Q3 FY2022 | Sep 30, 2022 | $87.00K | +278.3% |
| Q2 FY2022 | Jun 30, 2022 | $78.00K | +290.0% |
| Q1 FY2022 | Mar 31, 2022 | $38.00K | +192.3% |
| Q4 FY2021 | Dec 31, 2021 | $26.00K | +333.3% |
| Q3 FY2021 | Sep 30, 2021 | $23.00K | +360.0% |
| Q2 FY2021 | Jun 30, 2021 | $20.00K | +233.3% |
| Q1 FY2021 | Mar 31, 2021 | $13.00K | – |
| Q4 FY2020 | Dec 31, 2020 | $6.00K | – |
| Q3 FY2020 | Sep 30, 2020 | $5.00K | – |
| Q2 FY2020 | Jun 30, 2020 | $6.00K | – |
See a number that looks wrong?